Clinical Trials Directory

Trials / Completed

CompletedNCT04858087

Malawi International Center of Excellence in Malaria Research School-based Cohort

Epidemiology of Malaria in Malawi: Human Hosts and Parasites in Three Districts Part 2: Cross-sectional Surveillance (School-based Cohorts)

Status
Completed
Phase
Study type
Observational
Enrollment
786 (actual)
Sponsor
University of Maryland, Baltimore · Academic / Other
Sex
All
Age
5 Years – 15 Years
Healthy volunteers
Accepted

Summary

A school-based, prospective, cohort study was conducted to evaluate the epidemiology of P. falciparum (Pf) infections in school-age children and determine the impact of the screen-and-treat approach on Pf infection and anemia prevalence among students in two different transmission settings. Investigators aimed to evaluate how frequently malaria rapid diagnostic tests (mRDTs) fail to detect low-parasite-density infections as well as whether low-density infections contribute to the burden and health consequences of Pf infection in school-age children and whether they contain gametocytes, the parasite stage required for transmission from humans to mosquitos.

Detailed description

Students were enrolled in four schools in southern Malawi in the rainy (March-May) and dry season (Sept-Nov) of 2015. 15 students per grade-level (grades 1-8), were invited to participate. Following enrollment, students were evaluated at baseline for screening-and-treatment, and followed-up 1, 2 and 6 weeks later. At each follow-up visit, a blood sample was obtained for microscopy and molecular detection of parasites and students were interviewed about bed net use the night prior, current or recent illness, and use of antimalarial treatment. At the final visit, a mRDT and hemoglobin test were repeated, and parents were interviewed and portable medical records ("health passports") were reviewed to identify intercurrent fever or malaria treatment.

Conditions

Interventions

TypeNameDescription
OTHERScreening and treatmentStudents were screened by mRDTs and treated with artemether-lumefantrine if positive

Timeline

Start date
2015-03-24
Primary completion
2015-11-13
Completion
2015-11-13
First posted
2021-04-26
Last updated
2021-04-26

Source: ClinicalTrials.gov record NCT04858087. Inclusion in this directory is not an endorsement.